Dexamethasone-Loaded Poly(Lactic-Co-Glycolic) Acid Microspheres/Poly(Vinyl Alcohol) Hydrogel Composite Coatings for Inflammation Control
Authors:
- 1 December 2004
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 6 (6) , 887-897
Abstract
Background: Successful performance of implantable glucose biosensors for metabolic monitoring is dependent on tissue compatibility. Negative immunostimulatory tissue reactions that occur due to implantation-induced tissue injury and the prolonged presence of such sensors can lead to a loss of functionality and device failure. The use of novel poly(lactic-co-glycolic) acid (PLGA) microsphere/poly(vinyl alcohol) (PVA) hydrogel composite coatings for implantable biosensors to control localized inflammation and fibrosis at the sensor/tissue interface is reported. Methods: Dexamethasone-loaded PLGA microspheres were prepared using a solvent evaporation technique. Composites were fabricated by dispersing microspheres in PVA solution and performing freeze-thaw cycling. Composites were implanted into subcutaneous tissue of rats. In vitro and in vivo drug release kinetics were studied. Immunostimulatory response was determined through histopathological evaluation of excised tissue. Results: PLGA microsphere/PVA hydrogel composites achieved localized dexamethasone delivery with approximate zero-order release kinetics. A linear level A in vitro–in vivo correlation was observed (R2 = 0.97). Dexamethasone released at a steady rate of 0.17 µg/day was sufficient to control acute and chronic inflammation as well as fibrosis. Implantation of composites containing no drug led to significant infiltration of inflammation-mediating cells at the implant site characteristic of acute inflammation followed by proliferation of a fibrotic band surrounding the implant by week 3. Conclusions: PLGA microsphere/PVA hydrogel composites eluting dexamethasone were successful in controlling negative tissue reactions at the sensor–tissue interface by reducing the level of inflammation-mediation cells to those observed in normal tissue. These composites show promise as coatings for implantable biosensors to improve biocompatibility and prolong sensor lifetime.Keywords
This publication has 31 references indexed in Scilit:
- Tissue adhesiveness and host response of in situ photopolymerizable interpenetrating networks containing methylprednisolone acetateJournal of Biomedical Materials Research Part A, 2003
- Effect of composition of interpenetrating polymer network hydrogels based on poly(acrylic acid) and gelatin on tissue response: A quantitative in vivo studyJournal of Biomedical Materials Research Part A, 2003
- Oxaliplatin loaded PLAGA microspheres:: design of specific release profilesInternational Journal of Pharmaceutics, 2002
- Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat modelJournal of Pharmacy and Pharmacology, 2002
- The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheresJournal of Microencapsulation, 2002
- Implantable glucose sensors: Present status and future developmentsExperimental and Clinical Endocrinology & Diabetes, 2001
- Evaluation of orntide microspheres in a rat animal model and correlation to in vitro release profilesAAPS PharmSciTech, 2000
- A novelin vitro release technique for peptide-containing biodegradable microspheresAAPS PharmSciTech, 2000
- Stereoselective Disposition of Ibuprofen Enantiomer Sustained Release Microspheres in Rats: I. Bioavailability ConsiderationsDrug Delivery, 1999
- Properties of a heparin‐poly(vinyl alcohol) hydrogel coatingJournal of Biomedical Materials Research, 1983